TipHub

₹62

▼ -1 -1.59%

As of 27 Jul 2026 · delayed

NSE Listed

ESM · ESM 1
What does ESM · ESM 1 mean?
NSE · Enhanced Surveillance Measure (ESM 1)ESM is the micro/small-cap ramp brake: it fires when a sub-₹1000cr stock's price variation is extreme versus its peer universe, or it's loss-making with a stretched valuation. Practical meaning: intraday speculation is shut off (Trade-for-Trade — every purchase must be taken to delivery), margins go to 100%, and at Stage II price discovery moves to periodic call auctions inside a 2% band.Criteria: Micro / small-cap companies (main-board market-cap below ₹500 cr) shortlisted on objective price parameters — high-low price variation, close-to-close price variation and standard deviation. Stage I = 100% margin + a ≤5% price band + Trade-for-Trade; Stage II = a 2% price band + periodic call auction.Exchange notice · 2026-07-14

Nephro Care India Limited (NEPHROCARE)

Volume: 29,600Avg Vol 1W: 12,640Avg Vol 1M: 12,82052W Range:₹50.05₹183
NSE BSE www.nephrocareindia.com AI Report
Key Ratios
Checked 1d ago
Market Cap₹104 Cr
Current Price₹62
Previous Close₹63
High / Low (52w)₹183 / ₹50.05
Volume29,600
Avg Vol (1W)12,640
Avg Vol (1M)12,820
Stock P/E103.28
Book Value₹34.48
Dividend Yield0%
ROE5.9%
ROA1.4%
Revenue (TTM)₹48 Cr
Revenue Growth—
Profit Margin3.7%
Total Debt₹0 Cr
Shares Outstanding2 Cr
Face Value₹10
EPS (TTM)₹0.61
P/B1.83
Debt / Equity0
50 DMA₹69.16
200 DMA₹94.05
Day change-1.59%
SurveillanceESM · ESM 1
Price Chart
₹62▼ 56.23% · 1Y
₹174₹523.5L
2025-07-29
2026-07-27

20-day avg volume: 13K shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 70% YoY.
  • Company is loss-making at the latest annual result.
  • Stock trades at a high P/E of 103.
Quarterly Results
MetricDec 2025Mar 2026
Revenue₹23 Cr₹27 Cr
EBITDA₹1 Cr₹1 Cr
Net Profit₹0 Cr₹1 Cr
EPS0.26—
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Dec 2025Mar 2026
Revenue₹1 Cr₹2 Cr₹3 Cr₹17 Cr₹28 Cr₹48 Cr₹23 Cr₹27 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹3 Cr₹6 Cr₹5 Cr₹1 Cr₹1 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹2 Cr₹4 Cr₹4 Cr₹0 Cr₹1 Cr
EPS-14.78135.15-0.032.373.82.38——
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹1 Cr₹1 Cr₹5 Cr₹8 Cr₹21 Cr₹68 Cr
Total Liabilities₹1 Cr₹1 Cr₹4 Cr₹6 Cr₹6 Cr₹15 Cr
Equity₹0 Cr₹0 Cr₹0 Cr₹3 Cr₹15 Cr₹53 Cr
Total Debt——————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹0 Cr₹1 Cr₹4 Cr₹3 Cr₹9 Cr
Investing₹0 Cr₹-3 Cr₹-2 Cr₹-8 Cr₹-40 Cr
Financing₹0 Cr₹2 Cr₹0 Cr₹6 Cr₹35 Cr
Free Cash Flow₹0 Cr₹1 Cr₹4 Cr₹3 Cr₹9 Cr
Shareholding
Promoter 61.71% Institutions 2.25% Public 36.03%
Efficiency & Working Capital
ROCE8.4%
Interest Coverage35.1
Dividend Payout—
Debtor Days26 d
Inventory Days10 d
Payable Days30 d
Cash Conversion Cycle5 d
Working Capital Days35 d
Shareholding Details

As of 2026-06-30

Promoter61.7%
FII1%
DII1.3%
Institutions2.3%
Public36%
Promoter Pledge0%
No. of Shareholders1,900
Shareholding Pattern

Quarterly — figures in %. Latest 11 quarters.

PeriodApr 2024Apr 2024Jun 2024Jul 2024Jul 2024Sept 2024Dec 2024Mar 2025Sept 2025Mar 2026Jun 2026
Promoters85%85%85%61.4%61.4%61.4%61.4%61.4%61.5%61.7%61.7%
FIIs0%0%0%3%3%3.9%4.1%3.5%3.5%0.7%1%
DIIs15%0%0%9.3%0.7%0%0%0%0%1.3%1.3%
Public0%15%15%26.3%35%34.7%34.6%35.1%35.1%36.3%36%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders8585951,5511,5518501,0771,3911,6441,8451,900
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Pratim SenguptaShareholding of Promoter and Promoter Group61%1.01 Cr
Pradyot Kumar SenguptaShareholding of Promoter and Promoter Group0.3%48,000
Shila SenguptaShareholding of Promoter and Promoter Group0.3%48,000
Prasenjit SenguptaShareholding of Promoter and Promoter Group0.2%24,000
Board of Directors
NameDesignationYear
Pratim SenguptaChairman & Managing Director2025
Pritam SenguptaNon-Exec & Non-Independent Dir2025
Alo SenguptaIndependent Non Exe. Director2025
SAIKAT BISWASIndependent Non Exe. Director2025
SUDIP BARMANIndependent Non Exe. Director2025
Sutapa SenNon-Exec & Non-Independent Dir2025
Sandeep Shridhar GhateIndependent Non Exe. Director2025
Debashsh GhoshalNon Executive Director2025
SOUGATA SENGUPTACompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Income from IPD Services₹11 Cr23.3%
Income from OPD Services₹24 Cr51.7%
Income from sale of medicines from₹12 Cr25%
Others₹0 Cr0%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10201616
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-07Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000213
2025000-00-0
2025000011
Company Information
Incorporated2014
ChairmanPratim Sengupta
AuditorK K Chanani & Associates
Investor Email[email protected]
🌐 www.nephrocareindia.com ↗

📍 Flat No.1JC-18 5th Flr Sec-III, Salt Lake Bidhan Nagar Sai Cmp, Kolkata, West Bengal, 700098

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Nectar Lifesciences Ltd.Neelam Linens and Garments (India) Ltd.Nelcast LimitedNELCO Ltd.Neochem Bio Solutions Ltd.Neogen Chemicals LimitedNephrocare Health Serv LimitedNeptune Petrochemicals LimitedNesco Ltd.Nestle India LimitedNetweb Technologies India Ltd.Network 18 Media & Investments Ltd.All “N” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search